Trial Profile
Phase III Clinical Trial of tesevatinib in patients with glioblastoma
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Tesevatinib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 18 Dec 2015 The company expects to initiate this trial in 2016, according to a Kadmon Corporation media release.
- 22 Apr 2015 New trial record